|
AU4577502A
|
|
Process for stimulating neural regeneration
|
|
AU4439102A
|
|
Improved method for transferring nucleic acid into the striped muscle and combination therefor
|
|
AU2928102A
|
|
Adenovirus including a gene coding for a superoxide dismutase
|
|
AU2928402A
|
|
Recombinant viruses coding for a glutamate decarboxylase (GAD) activity
|
|
AU1360002A
|
|
Novel constructs and vectors for the targeted and inducible expression of genes
|
|
GB9920548D0
|
|
Treatment of hepatocellular carcinoma
|
|
US6288075B1
|
|
Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same
|
|
AU4444199A
|
|
Nucleic acid containing composition, preparation and uses of same
|
|
AU4445499A
|
|
Adenovirus including a gene coding for a superoxide dismutase
|
|
AU4348599A
|
|
Gene therapy for restenosis using an adenoviral vector
|
|
AU4237599A
|
|
Recombinant viruses, preparation and use thereof in gene therapy
|
|
AU4233499A
|
|
Recombinant viruses coding for a glutamate decarboxylase (GAD) activity
|
|
US6124465A
|
|
Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments
|
|
AU4044699A
|
|
Method for preparing aspartyl cyclohexylalaninamide
|
|
US6040466A
|
|
Taxoids, their preparation and pharmaceutical compositions containing them
|
|
AU2286099A
|
|
Di-substituted naphthyl derivatives, preparation thereof, pharmaceutical compositions containing them
|
|
AU1767599A
|
|
Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines
|
|
US6187746B1
|
|
Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
|
|
TWI242447B
|
|
An injectable pharmaceutical compositions of dalfopristine/quinupristine combination
|
|
FR2786469A1
|
|
"blister" type packaging, particularly for the packaging of breakable products such as tablets
|
